medigraphic.com
ISSN 1405-8790 (Print)

2011, Number 3

<< Back Next >>

Rev Mex Med Fis Rehab 2011; 23 (3)

Incidence of acute pyelonephritis in patients with myelomeningocele at the Teletón Children’s Rehabilitation Center, Chihuahua

Díaz GL, Parodi CA, Monroy ME

Language: Spanish
References: 41
Page: 83-90
PDF size: 123.38 Kb.


ABSTRACT

Introduction: The myelomeningocele implies neurogenic bladder, urinary tract infection and acute pyelonephritis. Objective: To determinate the incidence of acute pyelonephritis in patients with myelomeningocele of CRIT Chihuahua. Material and methods. Study of 70 patients of a total of 80. We excluded those with established kidney failure. We considered history, hematic citometry, uroanalysis, urocultive, kidney ultrasonography and cystometry. The analysis was by descriptive and interferential statistic (Chi square, analysis of frequencies and logistic regression with the program SPSS 15). Results: Age average of 10.1 years. Of the patients: 54 (77.1%) with abnormal uroanalysis; 53 (75.7%) with positive urocultive. Sixty-eight with abnormal bladder radiologically and 2 with normal bladder. Seven (10%) with vesicoureteral reflux grade I, 5 (7.1%) with RVU grade II, 3 (4.3%) with RVU grade III, 7 (10%) with RVU grade IV, 3 (4.3%) with RVU grade V. 45 (64.3%) without reflux. 38 (54.3%) patients with pyelonefritis by kidney USG; 37 (52.9%) with abnormal BH; 45 (64.3%) with urinary tract symptoms. 43 (61.4%) with acute pyelonefritis (PNA) by clinic, uroanalysis, urocultive, BH and kidney USG. There was statistic significance to correlate acute pyelonefritis with uroanalysis (p = a 0.002), PNA and urocultive (p = a 0.01). There wast’n statistic significance to correlate acute pyelonefritis with sex (p = 0.775). Conclusion: Patients with myelomeningocele and neurogenic bladder have a high incidence of acute pyelonefritis and urinary tract infections.


REFERENCES

  1. Padmanabhan R. Etiology, pathogenesis and prevention of neural tube defects. Congenital Anomalies 2006; 46: 55-67.

  2. Rodríguez M, Guerrero J, Parra M, Segura MJ, Levario M, Sotelo EI. Deficiencia de folatos y su asociación con defectos de cierre del tubo neural en el norte de México. Salud Pública Méx 1998; 40(6): 474-480.

  3. Aguiar M, Campos A, Aguiar R, Lana A, Magalhaes R, Babeto L. Neural tube defects and associated factors in liveborn and stillborn infants. J de Pediatr 2003; 79(2): 105-6.

  4. Ramírez EJ, Benavides FG, Lacasaña NM, Martínez JM, García AM, Benach J. Mortalidad por defectos del tubo neural en México, 2003; 45(5): 365.

  5. Moore KL. Embriología clínica. 3ª ed.; Ed. Iberamericana McGraw Hill. México D.F. 1988: 64-66,400.

  6. Kolaski K. Myelomeningocele. Emedicine 2006: 1-10.

  7. Fernández C, De la Fuente JM, Muñoz DJ, Del Río AM. Vejiga neurógena infantil. Clin Urol 2000; 8: 671-692.

  8. Bell JE, Gordon A, Maloney AF. The association of hydrocephalus and Arnold-Chiari malformation in fetus. Neurophath Appl Neurobiol 1980; 6: 29.

  9. Farley TL. A reproductive history of mothers with spina bifida offspring-a new look at old issues. Cerebrospinal Fluid Res 2006; 1(3): 10.

  10. Rintoul NE, Shutton LN, Hubbad AM, Cohen B, Melchionni J, Pasquariello P, Adzick SA. New look at myelomeningoceles: functional level, vertebral level, shunting, and the implications for fetal intervention. Pediatr 2002; 109(3): 408-413.

  11. Barkai G, Arbuzova S, Berkenstadt M, Heifetz S, Cuckle H. Frequency of Down’s syndrome and neural-tube defects in the same family. Lancet 2003; 361(9366): 1331-5.

  12. Ray JG, Wyatt PR, Vermeulen MJ, Meier C, Cole DE. Greater maternal weight and the ongoing risk of neural tube defects after folic acid flour fortification. Obstet Gynecol 2005; 105(2): 261-5.

  13. Hansen D, Lou HC, Olsen J. Serious life events and congenital malformations: a national study with complete follow-up. Lancet 2000; 356(9233): 875-80.

  14. Rothenberg SP, da Costa MP, Sequeira JM, Cracco J, Roberts JL, Weedon J, Quadros EV. Autoantibodies against folate receptors in women with a pregnancy complicated by a neural-tube defect. N Engl J Med 2004; 350(2): 134-42.

  15. Kirke PN, Mills JL, Molloy AM, Brody LC, O’Leary VB, Daly L, Murray S, Conley M, Mayne PD, Smith O, Scott JM. Impact of the MTHFR C677T polymorphism on risk of neural tube defects: Case-control study. BMJ 2004; 328: 1535-1536.

  16. Nualart L, Haces GF, Camacho FLA. Mielomeningocele gemelar (Reporte de un caso). Acta Ortop Mex 2006; 20(4): 169-171.

  17. Cherian A, Seena S, Bullock RK, Antony AC. Incidence of neural tube defects in the least-developed area of India: a population-based study. Lancet 2005; 366(9489): 871-2.

  18. Medina A. Coutiño B, Alvarado G, Ramírez J. Epidemiología del mielomeningocele en niños menores de un año de edad en el Instituto Nacional de Pediatría. Rev Mex Med Fís Rehab 2001; 13: 50-54.

  19. Williams LJ, Rasmussen SA, Flores A, Kirby RS, Edmonds LD. Decline in the prevalence of spina bifida and anencephaly by race/ethnicity: 1995-2002. Pediatr 2005; 116(3): 580-6.

  20. Quan A, Adams R, Ekmark E, Baum M. Bone mineral density in children with myelomeningocele. Pediatr 1998; 102(3): 34.

  21. Vermaes PR, Janssens JM, Bosman AM, Gerris JR. Parents psychological adjustment in families of children with Spina Bifida: a meta-analysis. BMC Pediatr 2005; 5(32): 1-13.

  22. Lemelle L, Guillemin F, Aubert D, Guys JM, Lottmann H, Lortat-Jacob S, Mouriquand P, Ruffion A, Moscovici J, Schmitt M. Quality of life and continence in patients with spina bifida. Qual of Life Res 2006; 15(9): 1481-1492.

  23. Medina LS, Crone K, Kuntz KM. Newborns with suspected occult spinal dysraphism: a cost-effectiveness analysis of diagnostic strategies. Pediat 2001; 108(6): 101.

  24. Kriss VM, Desai NS. Occult spinal dysraphism in neonates: assessment of high-risk cutaneous stigmata on sonography. Ajr Am J Roentgenol 1998; 171(6): 1687-92.

  25. Guggisberg D, Hadj-Rabia S, Viney C, Bodemer C, Brunelle F, Zerah M, Pierre-Kahn A, de Prost Y, Hamel-Teillac D. Skin markers of occult spinal dysraphism in children: a review of 54 cases. Arch Dermatol 2004; 140(9): 1153-5.

  26. Sival DA, van Weerden TW, Vles JS, Timmer A, den Dunnen WF, Staal-Schreinemachers AL, Hoving EW, Sollie KM, Kranen-Mastenbroek VJ, Sauer PJ, Brouwer OF. Neonatal loss of motor function in human spina bifida aperta. Pediatr 2004; 114(2): 427-34.

  27. Bruner JP, Tulipan N, Paschall RL, Boehm FH, Walsh WF, Silva SR, Hernanz-Schulman M, Lowe LH, Reed GW. Fetal surgery for myelomeningocele and the incidence of shunt-dependent hydrocephalus. JAMA 1999; 282(19): 1819-25.

  28. Chescheir NC, D’Alton M. Evidence-based medicine and fetal treatment: how to get involved. Obstet Gynecol 2005; 106(3): 610-3.

  29. Martínez AE, Burgués GJ, Alapont AJ. Vejiga neurógena. Conceptos básicos. Clin Urol 2000; 8: 283-347.

  30. Martinell J, Claesson I, Lidin-Janson G, Jodal U. Urinary infection, reflux and renal scarring in females continuously followed for 13-38 years. Pediatr Nephrol 1995; 9(2): 131-6.

  31. Yomayusa N, Altahona H. Guías para manejo de urgencias (Pielonefritis aguda). ed. 4a; Ed. Celsus; X: 1112-1119.

  32. Smith. Urología general de Smith. ed. 11ª; Ed. El Manual Moderno S.A. de C.V., México D.F., 1997: 209.

  33. Alconcher L, Tombesi M. Relación entre pielonefritis aguda, daño renal y reflujo vesicoureteral. Arch Argent Pediatr 2007; 105(3): 211-215.

  34. Bueno FA, Peña MM, Moreno PD. Reflujo vesicoureteral y neuropatía por reflujo. Protocolos diagnósticos y terapéuticos en pediatría. 223-230.

  35. Snodgrass WT, Adams R. Initial urologic management of myelomeningocele. Urol Clin North Am 2004; 31(3): 427-34.

  36. De la Peña E. Tratamiento del reflujo vesico-ureteral primario en la infancia: comparación de 2 revisiones sistemáticas. Actas Urol Esp 2005; 29(2): 138-162.

  37. Stone AR. Neurourologic evaluation and urologic management of spinal dysraphism. Neurosurg Clin N Am 1995; 6(2): 269-77.

  38. Jamison J, Maguire S, McCann J. Catheter policies for management of long term voiding problems in adults with neurogenic bladder disorders. Cochr Data Syst Rev 2004; 2(4375): 3.

  39. Schlager TA, Clark M, Anderson S. Effect of a single-use sterile catheter for each void on the frequency of bacteriuria in children with neurogenic bladder on intermittent catheterization for bladder emptying. Pediatr 2001; 108(4): 1-9.

  40. Favazza TF. Myelodysplasia and neurogenic bladder dysfunction. Emedicine 2005.

  41. Chung SY. Bladder tissue-engineering: a new practical solution? Lancet 2006; 367(9518): 1215-6.




2020     |     www.medigraphic.com